Subscribe to Newsletter
Diagnostics Genetics and epigenetics, Omics, Technology and innovation

Introducing New World of NGS - One Day Hands Free solution to fit in any lab

sponsored by Thermo Fisher Scientific

Now available on demand

December 5, 2019
16:00 GMT

Whilst NGS has been instrumental to precision oncology research progress, practical hurdles have still been hindering its broad implementation…………Not anymore.

Thermo Fisher Scientific has just introduced the Ion Torrent Genexus System, the first fully integrated, NGS platform featuring an automated specimen to report workflow that delivers results economically in a single day.

In combination with new Oncomine Precision Assay, the Genexus system represents a next generation solution for genomic profiling and set the stage for the molecular pathology labs in the future perform genomic profiling with speed and simplicity of traditional testing modalities, such as immunohistochemistry.

During this webinar you will learn

  1. How Genexus System is addressing key challenges to NGS implementation, such as high level of expertise and hands on work requirements as well as cost and time to result.
  2. Why in combination with new Oncomine Precision Assay it composes a new generation solution for genomic profiling of cancer samples.
  3. About experience of the first laboratory which is implementing this solution – IPATIMUB in Portugal.

Now available on demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Evaluation of cell-free fetal DNA to determine fetal RhD status

| Contributed by Revvity

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Enabling Efficient, Cost-effective Sequencing of the Human Whole Exome

| Contributed by Revvity

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register